R. Loch Macdonald - Net Worth and Insider Trading

R. Loch Macdonald Net Worth

The estimated net worth of R. Loch Macdonald is at least $78,172 dollars as of 2024-06-20. R. Loch Macdonald is the Chief Scientific Officer of PDS Biotechnology Corp and owns about 28,530 shares of PDS Biotechnology Corp (PDSB) stock worth over $78,172. Details can be seen in R. Loch Macdonald's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that R. Loch Macdonald has not made any transactions after 2018-03-22 and currently still holds the listed stock(s).

Transaction Summary of R. Loch Macdonald

To

R. Loch Macdonald Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, R. Loch Macdonald owns 2 companies in total, including PDS Biotechnology Corp (PDSB) , and Acasti Pharma Inc (ACST) .

Click here to see the complete history of R. Loch Macdonald’s form 4 insider trades.

Insider Ownership Summary of R. Loch Macdonald

Ticker Comapny Transaction Date Type of Owner
PDSB PDS Biotechnology Corp 2018-03-22 director & Chief Scientific Officer
ACST Acasti Pharma Inc 2023-07-14 Chief Medical Officer

R. Loch Macdonald Latest Holdings Summary

R. Loch Macdonald currently owns a total of 1 stock. R. Loch Macdonald owns 28,530 shares of PDS Biotechnology Corp (PDSB) as of March 22, 2018, with a value of $78,172.

Latest Holdings of R. Loch Macdonald

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDSB PDS Biotechnology Corp 2018-03-22 28,530 2.74 78,172

Holding Weightings of R. Loch Macdonald


R. Loch Macdonald Form 4 Trading Tracker

According to the SEC Form 4 filings, R. Loch Macdonald has made a total of 0 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years. The most-recent trade in PDS Biotechnology Corp is the sale of 125 shares on March 22, 2018, which brought R. Loch Macdonald around $41,025.

Insider Trading History of R. Loch Macdonald

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

R. Loch Macdonald Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

R. Loch Macdonald Ownership Network

Ownership Network List of R. Loch Macdonald

No Data

Ownership Network Relation of R. Loch Macdonald

Insider Network Chart

R. Loch Macdonald Owned Company Details

What does PDS Biotechnology Corp do?

Who are the key executives at PDS Biotechnology Corp?

R. Loch Macdonald is the director & Chief Scientific Officer of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .

PDS Biotechnology Corp (PDSB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PDS Biotechnology Corp Insider Transactions

No Available Data

R. Loch Macdonald Mailing Address

Above is the net worth, insider trading, and ownership report for R. Loch Macdonald. You might contact R. Loch Macdonald via mailing address: 200 Connell Drive, Suite 1600, Berkeley Heights Nj 07922.

Discussions on R. Loch Macdonald

No discussions yet.